Study of Circulating Tumoral DNA in Metastatic Choroidal Melanoma
NCT01334008 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40
Last updated 2025-11-24
Summary
Circulating tumor DNA detection and quantification in patients with metastatic choroidal melanoma.
Conditions
- Choroidal Melanoma, Diffuse
Interventions
- BIOLOGICAL
-
Blood sampling
30ml of patient peripherical blood will be collected
Sponsors & Collaborators
-
Institut Curie
lead OTHER
Principal Investigators
-
Sophie PIPERNO-NEUMANN, MD · Institut Curie
Study Design
- Allocation
- NA
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2011-04-30
- Primary Completion
- 2012-02-29
- Completion
- 2012-05-31
Countries
- France
Study Locations
More Related Trials
-
Real-time Monitoring of Concentration and Size Variations of Circulating Plasma Free DNA to Predict Early Response to Immunotherapies in Patients With Different Types of Cancer.
NCT05083494 ·Status: UNKNOWN
-
Circulating Tumor DNA and Follow-up of BRCA1 Mutation Carriers (CirCa 01)
NCT02608346 ·Status: COMPLETED ·Phase: NA
-
Validation of a Molecular Prognostic Test for Eye Melanoma
NCT00406120 ·Status: WITHDRAWN
-
Cytogenetic Study of Ocular Melanoma
NCT00344799 ·Status: COMPLETED
-
Detection of Melanoma Markers in Lymph Nodes or Peripheral Blood of Patients With Melanoma
NCT00004153 ·Status: COMPLETED ·Phase: NA
-
Analysis of Circulating Tumor Markers in Blood
NCT04025541 ·Status: RECRUITING ·Phase: NA
-
Identification of Marker of Primary or Acquired Resistance to Anti Tumorous Treatment
NCT02105168 ·Status: UNKNOWN ·Phase: NA
-
CIRculating Cell-free nUcLeic Acids in Cancer Therapy Monitoring -01
NCT05871593 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Feasibility Study of a Molecular Karyotype Using a Very High-throughput Sequencing Approach, the "Massive Parallel Sequencing" on Circulating Tumor DNA
NCT04104633 ·Status: COMPLETED ·Phase: NA
-
Molecular Screening for Cancer Treatment Optimization
NCT01566019 ·Status: UNKNOWN ·Phase: NA
-
Detection of Plasmatic Cell-free BRAF and NRAS Mutations : a New Tool for Monitoring Patients with Metastatic Malignant Melanoma Treated with Targeted Therapies or Immunotherapy ( MALT )
NCT03493230 ·Status: COMPLETED ·Phase: NA
-
Genetic Analysis of Blood and Tissue Samples From Patients With Advanced Cancer, Moonshot Study
NCT03707574 ·Status: COMPLETED
-
Improving Early Detection of Melanoma Recurrence With Circulating Tumor DNA (ctDNA)
NCT05736523 ·Status: ACTIVE_NOT_RECRUITING
-
Characterization & Comparison of Drugable Mutations in Primary and Metastatic Tumors, CTCs and cfDNA in MBCpatients
NCT02626039 ·Status: COMPLETED
-
Sample Collection Study in Patients With Suspected Melanoma Utilizing DermTech's Non-invasive Adhesive Patch Biopsy Kits
NCT04550000 ·Status: COMPLETED
-
Circulating Tumor DNA Study in Patients With Endometrial Cancer
NCT05955079 ·Status: RECRUITING
-
Studying Tumor Tissue Samples From Patients With Melanoma Who Have Undergone Sentinel Lymph Node Biopsy
NCT00897481 ·Status: UNKNOWN
-
Measurement and Characterization of Circulating Endothelial Cells or Circulating Tumor Cells or Circulating DNA in Adult Patients With Metastatic Cancer
NCT02666612 ·Status: UNKNOWN ·Phase: NA
-
"Principle Test" for Isolation and Characterization of Circulating Cancer Cells (CTC)-CXCR4+.
NCT05818865 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Biomarkers in Predicting Response to Chemotherapy in Patients With Advanced or Metastatic Melanoma Previously Treated With Carboplatin and Paclitaxel With or Without Sorafenib Tosylate
NCT01209299 ·Status: COMPLETED
-
Assessment of Circulating Tumor Cells and microRNAs in Patients With Metastatic Non-cutaneous Melanoma
NCT06863870 ·Status: ACTIVE_NOT_RECRUITING
-
Study on the Contribution of the Genetic Tumor Profile Obtained by Circulating Tumor DNA Analysis in the Multidisciplinary Molecular Biology Meeting of Eastern PACA
NCT06606366 ·Status: RECRUITING ·Phase: NA
-
Prediction of Residual Disease by Circulating DNA Detection After Potentiated Radiotherapy for Locally Advanced Head and Neck Cancer
NCT05710679 ·Status: RECRUITING ·Phase: NA
-
Circulating DNA in Surgically Treated NSCLC
NCT04037150 ·Status: UNKNOWN
-
Cell-free Circulating DNA in Primary Cutaneous Lymphomas
NCT02883517 ·Status: COMPLETED